Back to Search Start Over

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.

Authors :
Houlahan, Kathleen E.
Salmasi, Amirali
Sadun, Taylor Y.
Pooli, Aydin
Felker, Ely R.
Livingstone, Julie
Huang, Vincent
Raman, Steven S.
Ahuja, Preeti
Sisk, Anthony E.
Boutros, Paul C.
Reiter, Robert E.
Source :
European Urology. Jul2019, Vol. 76 Issue 1, p18-23. 6p.
Publication Year :
2019

Abstract

Multiparametric magnetic resonance imaging (mpMRI) has transformed the management of localized prostate cancer by improving identification of clinically significant disease at diagnosis. Approximately 20% of primary prostate tumors are invisible to mpMRI, and we hypothesize that this invisibility reflects fundamental molecular properties of the tumor. We therefore profiled the genomes and transcriptomes of 40 International Society of Urological Pathology grade 2 tumors: 20 mpMRI-invisible (Prostate Imaging-Reporting and Data System [PI-RADS] v2 <3) and 20 mpMRI-visible (PI-RADS v2 5) tumors. mpMRI-visible tumors were enriched in hallmarks of nimbosus, an aggressive pathological, molecular, and microenvironmental phenomenon in prostate cancer. These hallmarks included genomes with increased mutation density, a higher prevalence of intraductal carcinoma/cribriform architecture pathology, and altered abundance of 102 transcripts, including overexpression of noncoding RNAs such as SCHLAP1. Multiple small nucleolar RNAs (snoRNAs) were identified, and a snoRNA signature synergized with nimbosus hallmarks to discriminate visible from invisible tumors. These data suggest a confluence of aggressive molecular and microenvironmental phenomena underlie mpMRI visibility of localized prostate cancer. We examined the correlation between tumor biology and magnetic resonance imaging (MRI) visibility in a group of patients with low- intermediate-risk prostate cancer. We observed that MRI findings are associated with biological features of aggressive prostate cancer. Genome-wide copy number alteration and transcriptomic profiling of tumors invisible and visible on multiparametric magnetic resonance imaging (mpMRI) identified a confluence of aggressive transcriptomic, genomic, and pathological hallmarks correlated with mpMRI visibility. This work provides a molecular basis for the observation that mpMRI-visible tumors are clinically more aggressive. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03022838
Volume :
76
Issue :
1
Database :
Academic Search Index
Journal :
European Urology
Publication Type :
Academic Journal
Accession number :
136768926
Full Text :
https://doi.org/10.1016/j.eururo.2018.12.036